Date published: 2026-5-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

ANKRD25 Inhibitors

ANKRD25 inhibitors are a class of chemical compounds designed to specifically target and inhibit the activity of ANKRD25, a protein belonging to the ankyrin repeat domain (ANKRD) family. Proteins in this family are characterized by ankyrin repeat motifs, which are known to mediate protein-protein interactions. ANKRD25 is involved in various cellular processes, including signal transduction, protein regulation, and intracellular organization. By participating in these processes, ANKRD25 helps modulate cellular responses and the interactions between different proteins. Inhibitors of ANKRD25 disrupt these protein-protein interactions, thereby affecting the pathways in which ANKRD25 is involved.

Structurally, ANKRD25 inhibitors can vary widely depending on their mode of action. Some may interact directly with the ankyrin repeat motifs, preventing ANKRD25 from binding to its target proteins. Others may alter the protein's conformation, hindering its ability to participate in cellular complexes or interfere with its localization within the cell. These inhibitors provide valuable insights into the role of ANKRD25 in biological systems, particularly in terms of how it regulates cellular processes such as protein folding, signal transduction, and the organization of structural complexes within cells. By inhibiting ANKRD25, researchers can dissect the specific pathways and interactions in which this protein plays a key role, offering a deeper understanding of the molecular mechanisms that govern cellular functions, protein networks, and structural integrity.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

As a MEK inhibitor, PD98059 can inhibit the MAPK/ERK pathway, which may be involved in the cellular processes that ANKRD25 participates in. The inhibition can affect ANKRD25's functionality indirectly.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

This compound is a p38 MAPK inhibitor. By inhibiting p38, it can indirectly affect the signaling cascades where ANKRD25 is a player, modulating its function.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK inhibitor SP600125 can modulate the JNK signaling pathway, potentially affecting ANKRD25, which may have roles in these pathways.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

By inhibiting PI3K, LY294002 can impact AKT phosphorylation and thereby potentially influence the pathways involving ANKRD25.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin is another PI3K inhibitor that can indirectly modulate the activity of ANKRD25 by affecting PI3K-AKT signaling.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

This compound inhibits Rho-associated kinase and can modulate cytoskeleton dynamics, thereby potentially influencing the functions or localization of ANKRD25.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin inhibits mTOR, and by doing so, can impact various signaling pathways that may involve ANKRD25.

BAPTA/AM

126150-97-8sc-202488
sc-202488A
25 mg
100 mg
$138.00
$458.00
61
(2)

This is a calcium chelator. By modulating intracellular calcium levels, it can indirectly affect calcium-dependent signaling pathways where ANKRD25 may function.

KN-93

139298-40-1sc-202199
1 mg
$182.00
25
(1)

KN-93 inhibits CaMKII, thereby influencing calcium signaling. This can indirectly impact the functional scope of ANKRD25 within cellular signaling frameworks.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

As a tyrosine kinase inhibitor, Genistein can indirectly affect the phosphorylation status of proteins within the signaling pathways where ANKRD25 is involved.